Confoundle · a reasoning trap

Length-time bias

A test you run every few months finds slow-growing disease far more easily than fast-growing disease, because slow disease sits there for years waiting to be found while fast disease erupts between visits. Slow disease also has a better outlook whatever anyone does. So the cases a screening programme catches are the gentle ones, and they do well, and the programme takes the credit. The only number that cannot be gamed this way is deaths in everyone offered screening, whether or not they attended.

The rule

Screening does not sample disease fairly. It catches the slow-growing kind preferentially, and the slow kind was always going to do better, so screen-detected cases flatter the test.

What it looks like

Screened men whose lung cancer was found died of it less often. Did the screening save them?9,211 male smokers were randomly assigned either to chest x-rays and sputum tests every four months for six years, or to usual care, and followed for two decades. Among the men who were diagnosed with lung cancer, 65 percent of the intensively screened died of it, against 74 percent of the others.
Count everyone, and the screened arm did no better.The screened men were diagnosed far more often, 206 against 160, in a trial that split them evenly. The extra cancers were not a random sample of the disease. A test applied every few months catches the slow-growing tumours, because slow ones sit in the detectable stage for years waiting to be found, while fast ones surface between visits. Slow tumours also do better whatever you do, and some would never have surfaced at all. Those cases join the pool of people with lung cancer and survive it, so the share dying falls. Nobody was saved:

Three effects travel together here and this trial cannot separate them: the slow cases are caught preferentially (length-time), the clock starts earlier for those caught (lead-time), and some tumours found would never have caused harm (overdiagnosis). All three flatter the diagnosed group and none of them postpones a death. The number that stayed honest is deaths among everyone randomised, and it did not fall.

Why it works

Picture the same disease arriving in two speeds. Slow tumours spend years in the window where a test could find them but the patient feels nothing. Fast ones cross that window in weeks. Now sample the population every six months. You will find nearly all the slow ones and almost none of the fast ones, because the fast ones announce themselves between your visits. So the pile of screen-detected cases is loaded with indolent disease, and the pile of symptom-detected cases is loaded with aggressive disease, before treatment enters the story at all. Compare their outcomes and screening looks wonderful. At the extreme edge of this sits overdiagnosis: disease so slow it would never have troubled the person in their lifetime, which counts as a cancer found and cured while doing nothing but harm through the treatment. The defence is the same one that beats lead-time bias, and it is the reason screening programmes are judged the way they are: randomise who is invited, then count deaths in everyone invited, attended or not, diagnosed or not.

Source

Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92(16):1308-1316. Counts among the diagnosed are Table 3 (p. 1312); counts among everyone randomised are Table 2 (p. 1311).

See if it fools you

This page gives the answer away. The puzzle version shows you the same figures first and asks you to commit before the reveal.

Play this one